Artificial intelligence is rapidly transforming modern healthcare, combining technologies that improve diagnosis, treatment, research, and healthcare operations. From detecting diseases in medical scans to streamlining hospital workflows, AI is increasingly helping clinicians make faster and more data-driven decisions. While once viewed as a futuristic concept, many AI-powered tools are already becoming part of everyday medical practice.

Modern AI in medicine combines technologies such as machine learning, computer vision, natural language processing, and generative AI to support both clinical care and healthcare operations. In India, this shift toward preventive and digital healthcare is accelerating rapidly. According to an IMARC Group report, India’s AI healthcare market was valued at USD 435.7 million in 2025 and is projected to reach USD 4.77 billion by 2034.

India’s healthcare ecosystem is also undergoing rapid digital transformation. A recent Grand View Research industry report on India’s digital health market highlights growing adoption of telehealth platforms, AI-assisted diagnostics, remote patient monitoring and digital health infrastructure across the country. As healthcare systems become increasingly technology-enabled, future physicians will need to develop clinical expertise alongside the ability to work with data-driven healthcare tools and digital care ecosystems.

AI in medical imaging and diagnostics

One of the clearest examples of AI’s success in healthcare has emerged in medical imaging. AI-powered computer vision systems are increasingly being used to help clinicians detect abnormalities in radiology scans with greater speed and accuracy. Breast cancer screening has become one of the most studied use cases.

A large India-led study involving over 100,000 women assessed the use of an AI-based breast cancer screening tool for population-level screening and reported that AI-supported screening could improve early cancer detection while overcoming infrastructure and specialist shortages in large-scale public health settings.

These imaging tools have seen relatively smoother adoption because they are designed for narrow, measurable tasks. Their performance can be validated against standardized clinical benchmarks such as sensitivity, specificity, and detection rates. Importantly, these systems are intended to support physicians rather than replace them, functioning as a second layer of review that helps reduce workload while improving diagnostic confidence.

Personalized medicine and the role of AI

Another major area of interest has been personalized medicine, where treatments are tailored to an individual’s genetic profile. Since the Human Genome Project in the 1990s, researchers have hoped that advances in genomics and computational medicine would enable highly individualized therapies. While significant progress has been made, especially in oncology biomarker testing, many AI-driven applications in drug discovery and precision medicine still remain at the research or pre-clinical stage.

AI has nevertheless accelerated parts of the research process. Tools such as protein-structure prediction models and machine learning systems are helping researchers identify potential drug targets more efficiently than before. However, translating computational discoveries into approved clinical therapies still requires years of testing, validation, and regulatory review. As a result, personalized medicine continues to evolve gradually rather than transforming healthcare overnight.

Generative AI in healthcare

Generative AI has emerged as one of the most discussed technologies in medicine over the last few years. Much of its real-world adoption currently remains concentrated around administrative and operational workflows rather than direct clinical decision-making. AI tools are increasingly being used for functions such as claims coding, prior-authorization reviews, clinical documentation, and patient record summarization, helping healthcare systems improve efficiency and reduce administrative burden.

Although generative AI systems can process medical information and respond effectively to standardized medical questions, patient care still depends heavily on contextual understanding, ethical judgment, communication, and decision-making in uncertain situations. Concerns around transparency and explainability also continue to limit AI’s role in high-stakes clinical environments. As a result, AI is unlikely to replace physicians in critical diagnostic or therapeutic decisions in the near future. Instead, it is expected to remain a supportive tool that enhances efficiency while clinicians retain final responsibility for patient care.

The future of healthcare lies in human-AI collaboration

The future of healthcare is unlikely to involve AI replacing doctors entirely. Instead, AI is expected to increasingly manage repetitive, structured, and data-heavy tasks, while clinicians continue to lead areas requiring empathy, communication, contextual reasoning, and complex judgment.

Core clinical skills such as patient interaction, history-taking, physical examination, and ethical decision-making will remain central to medical practice. At the same time, healthcare professionals will increasingly need to understand the strengths and limitations of AI tools, critically evaluate AI-generated outputs, and identify potential errors or bias.

As healthcare continues to evolve, physicians who can effectively combine clinical expertise with technological understanding will likely be best positioned to lead the next generation of patient care.

(The article is authored by Stephan Bandelow, BSc, MSc, Dphil, Associate Professor, Associate Director, Researcher, St. George’s University, Grenada, West Indies)

Mumbai, 20th February 2026: PharmEasy, one of India’s leading healthcare platforms, has partnered with Samsung Health as part of the newly launched ‘Find Care’ feature, enabling users to access essential healthcare services directly within the Samsung Health app.

The partnership is aligned with PharmEasy’s mission to make healthcare more accessible, affordable, and convenient across India. With this integration, Samsung Health users can now order medicines, book lab tests and online consultations without switching apps, while continuing to track their overall wellbeing on Samsung Health.

As part of this collaboration, Samsung Health users will receive 6 months of complimentary PharmEasy Plus membership. The membership offers additional savings on medicines, lab tests and healthcare products, extra PharmEasy credits and free delivery benefits — helping users reduce overall healthcare spending while managing their health needs more easily.

The integration brings PharmEasy’s comprehensive healthcare services into a platform already used by millions to monitor fitness, heart health, sleep, and overall wellbeing. By combining health tracking with access to trusted healthcare services, the collaboration aims to make everyday health management more seamless and connected.

Commenting on this landmark partnership, Gaurav Verma, Chief Business Officer at PharmEasy (API Holdings), said:

“Our collaboration with Samsung Health marks a significant step in integrating everyday technology with accessible healthcare. By bringing PharmEasy’s medicines, diagnostics, and healthcare services directly to Samsung users, we are enabling access to a seamless, end-to-end healthcare experience. The partnership also includes 6 months of complimentary PharmEasy Plus membership, offering added savings, free delivery benefits and much more. Together, this initiative empowers users with greater value, accessibility, and control over their healthcare journey. It is a meaningful stride toward building a more connected, affordable, and user-centric healthcare ecosystem in India.”

“Our goal is to make healthcare more accessible and convenient for everyone. By integrating ‘Find Care’ Service in the Samsung Health app we are taking a significant step towards achieving this vision.  ‘Find Care’ has been thoughtfully designed to meet the evolving needs of our users. We are committed to continuously innovating and enhancing our services to improve our user’s experience,” said Kyungyun Roo, Managing Director, Samsung Research Institute, Noida.

Samsung Health is a global wellness and lifestyle platform that enables users to monitor physical activity, heart health, sleep patterns, and other key health indicators. With the addition of healthcare access through ‘Find Care’, users can now manage both their wellbeing and healthcare needs in a more integrated way.

This partnership reflects PharmEasy’s continued focus on improving healthcare accessibility through digital innovation and strengthening its role as a 360-degree platform for users across their healthcare journey.